The 17th annual World Vaccine Congress and the  Immune Profiling Congress US 2017 is the place where the global vaccine industry meets to discuss commercial and scientific issues around regulation, strategy, manufacturing, clinical trials, partnering, influenza, cancer, emerging diseases and veterinary.


Dr Dicky Abraham, Executive Director, Project Leadership Group, Global Vaccine and Biologics Commercialization, Merck

Dr Rodolfo Alarcón, Program Officer, Enteric & Hepatic Diseases Branch (HNM55)

Dr David E. Anderson, Senior Vice President, Research, Vbi Vaccines

Mr Bo Arve, Executive Director, Pfizer Vaccine Research

Mr Bo Arve at World Vaccine Congress Washington 2017

Dr Alison Deckhut Augustine, Branch Chief Basic Immunology, N.I.A.I.D. N.I.H.

Professor Laure Aurelian, Professor, University of Maryland School of Medicine

Professor Laure Aurelian at World Vaccine Congress Washington 2017

Dr Luigi Aurisicchio, Chief Executive Officer, EVVIVAX SRL

Professor Fikri Avci, Assistant Professor of Biochemistry and Molecular Biology, UGA Center for Molecular Medicine

Dr Mark Bagarazzi, Chief Medical Officer, Inovio

Dr Jessica Baker Flechtner, Chief Scientific Officer, Genocea Biosciences, Inc.

Dr Ripley Ballou, VP & Head, GSK Global Vaccines US R&D Center, GSK Vaccines

Dr Ripley Ballou at World Vaccine Congress Washington 2017

Dr Roy Baynes, SVP of Head Global Clinical Development, CMO, Merck Research Laboratories (MSD)

Dr Roy Baynes at World Vaccine Congress Washington 2017

Dr Rodolfo Bellinzoni, Chief Operating Officer, Biogenesis Bago S.A.

Dr Wolfgang Bender, Chief Medical Officer, Valneva

Dr Jay A. Berzofsky, Branch Chief, Vaccine Branch, National Cancer Institute - NIH

Dr Pamuk Bilsel, Vice President Research and Development, FluGen Inc

Lynlee Burton, Director of Project Delivery - Vaccines, PRA Health Sciences

Dr Danilo Casimiro, CSO, AERAS

Dr Cristina Cassetti, Program Officer Acute Viral Diseases, Virology Branch, NIAID, National Institutes of Health (NIH)

Peter W. Che, International Business Manager, Repertoire Genesis, Inc

Dr Roman Chicz, Associate Vice President and Global Head Of External Research and Development, Sanofi Pasteur Inc

Dr Giuseppe Ciaramella, Chief Scientific Officer, Valera

Giovanni Della Cioppa, Head of R&D Center, GSK Vaccines

Dr Tim Cooke, Chief Executive Officer, NovaDigm Therapeutics

Dr Craig Curtis, Chief Medical Officer, Compass Research, Bioclinica Research Network

Ms Michele D'Alessandro, Vice President &Chief Information Officer, Manufacturing IT, Merck & Co.

Dr Lisa Danzig, Vice President, Clinical Development and Medical Affairs, PaxVax

Professor Robert Daum, Professor of Pediatrics, The University of Chicago

Professor Mark M Davis, Professor, Microbiology & Immunology, Director, Stanford Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine

Professor Mark M Davis at World Vaccine Congress Washington 2017

Dr Annie De Groot, Chief Executive Officer, Chief Scientific Officer and Director, EpiVax Inc

Giuseppe Del Giudice, Translational Science Leader, GSK Vaccines

Giuseppe Del Giudice at World Vaccine Congress Washington 2017

Dr Lelia Delamarre, Group Leader, Cancer Immunotherapy Department, Genetech

Dr Rakesh Dixit, Vice President R&D, Global Head, Biologics Safety Assessment, MedImmune Inc

Dr Rakesh Dixit at World Vaccine Congress Washington 2017

Dr Donald Drake, Senior Director of Immunological Research, Sanofi Pasteur Inc

Devon DuBose, Director of Early Phase Formulation and Process Development, Capsugel

Dr Cynthia Dukes, Vice President - Global Project Management, ICON

Dr John El-Attrache, Director of Scientific Services, Ceva Animal Health

Dr John El-Attrache at World Vaccine Congress Washington 2017

Dr Veronica Gambillara Fonck, Co-Founder & Chief Executive Officer, LimmaTech Biologics AG

Dr Bernard Fox, Harder Family Endowed Chair for Cancer Research Member and Chief, Lab of Molecular and Tumor Immunology, Oregon Health and Science University and Knight Cancer Institute

Dr Bernard Fox at World Vaccine Congress Washington 2017

John Fraser, Dean of the Faculty of Medical and Health Sciences, University Of Auckland

John Fraser at World Vaccine Congress Washington 2017

Dr Patrick Frayssinet, R&D Director, URODELIA

Dr Patrick Frayssinet at World Vaccine Congress Washington 2017

Dr Leonard Friedland, VP, Scientific Affairs and Public Health Vaccines, North America, GSK

Dr Nathalie Garcon, CEO/CSO, BIOASTER

Dr Cyril Gay, Senior National Program Leader, A.R.S. National Programs

Dr Cyril Gay at World Vaccine Congress Washington 2017

Dr Bruce Gellin, Former Director National Vaccine Program Office, National Vaccine Program Office

Professor Volker Gerdts, Professor of W.C.V.M. and Associate Director of Research, Vaccine and Infectious Disease Organizatio, VIDO-InterVac

Professor Volker Gerdts at World Vaccine Congress Washington 2017

Dr Jens Gertow, Scientific Advisor, Mabtech

Mr Basav Ghosh, Sr. Director, Pfizer

Dr Renald Gilbert, Team Leader of Viral Vector Production, N.R.C. Canada

Dr Anthony Gilbert, Medical Director, hVIVO

Dr Anthony Gilbert at World Vaccine Congress Washington 2017

Douglas Gladue, Senior Scientist, Plum Island Animal Disease Center, Usda

Dr Gregory Glenn, Senior Vice President of Research and Development, Novavax

Dr Akshay Goel, Senior Vice President - R&D, Biological E. Limited

Dr Akshay Goel at World Vaccine Congress Washington 2017

Mr Bruno Gomes, Head of Tumor Immunology, iTeos Therapeutics

Nesya Goris, Chief Development Officer & Co-Founder, ViroVet

Nesya Goris at World Vaccine Congress Washington 2017

Dr Barney Graham, Deputy Director of Vaccine Research Center, National Institute of Allergy and Infectious Diseases

Dr Luis H. Martin, Chief Executive Officer, Pan-Provincial Vaccine Enterprise Inc. (PREVENT)

Dr Luis H. Martin at World Vaccine Congress Washington 2017

Dr Emmanuel Hanon, Senior Vice President, Head of Vaccines R&D,, GSK Vaccines

Dr Emmanuel Hanon at World Vaccine Congress Washington 2017

Dr Ali M. Harandi, Lab head, Dpt of Microbiology & Immunology, University of Gothenburg

Dr Ali M. Harandi at World Vaccine Congress Washington 2017

Gareth Harris, Assoc. Vice President, Regulatory Affairs, Merck and Co Inc

Dr Audray Harris, Chief of Structural Informatics Unit Laboratory of Infectious Diseases, National Institutes of Health

Ms Penny Heaton, Director of Vaccine Development, The Bill and Melinda Gates Foundation

Ms Penny Heaton at World Vaccine Congress Washington 2017

Dr Hanjo Hennemann, Chief Scientific Officer and Co Founder, VEROVACCiNES

Dr Gray Heppner, Chief Medical Officer, New Link Genetics

Dr Gray Heppner at World Vaccine Congress Washington 2017

Dr Alan R. Hinman, Director for Programs, Center for Vaccine Equity, Task Force for Global Health

Dr Stephen Hoffman, Chief Executive and Scientific Officer, Sanaria Inc

Dr Peter Hotez, Dean of National School of Tropical Medicine, Baylor College of Medicine & President, Sabin Vaccine Institute

Mr Pascal Hudelet, Director of Veterinary Public Health Operations, Merial, A SANOFI Company

Dr Jeff Hutchins, Vice President of Pre Clinical Research, Peregrine Pharmaceuticals Inc

Dr Jeff Hutchins at World Vaccine Congress Washington 2017

Dr James Jackson, Chief Scientific Officer, Emergent BioSolutions

Dr James Jackson at World Vaccine Congress Washington 2017

Dr Renaud Jacquemart, Director Vaccines Process Sciences, Natrix Separations

Dr Kathrin Jansen, Senior Vice President For Vaccine Research and Development, Pfizer

Dr Robert Janssen, Chief Medical Officer of Vice President Clinical Development, Dynavax Technologies

Dr Anass Jawhari, Chief Scientific Officer and Director of R and D, Calixar

Dr Anass Jawhari at World Vaccine Congress Washington 2017

Dr Joseph Joyce, Director, Vaccine Process Development, Merck & Co.

Dr Michael Kalos, Chief Scientific Officer, Eli Lilly and Co

Dr David Kaufman, Executive Director of Translational Immune Oncology Lead and Oncology Clinical Research, Merck & Co.

Dr David Kaufman at World Vaccine Congress Washington 2017

Dr Howard Kaufman, Chief Surgical Officer, Assoc Director, Rutgers Cancer Institute of New Jersey

Dr Cheryl Keech, Executive Medical Director, PPD Vaccines

Dr Cheryl Keech at World Vaccine Congress Washington 2017

Mr Chris Kemp, President, Kempbio Inc

Dr Samir Khleif, Director of Immunotherapy and Immune Oncology Program, Georgia Regents University Cancer Center

Dr Jerome Kim, Director-General, International Vaccine Institute

Dr Wayne C Koff, President and CEO - The Human Vaccines Project, International Aids Vaccine Initative Inc

Dr Wayne C Koff at World Vaccine Congress Washington 2017

Dr Michael Kowarik, Co-Founder & Vice President Research and IP, LimmaTech Biologics AG

Professor Florian Krammer, Associate Professor, Department of Microbiology, Icahn School of Medicine at Mount Sinai

Lakshmi Krishnan, Group Leader-Senior Research Officer, National Research Council

Dr Mahesh Kumar, Vice President, Global Biologics Research, Zoetis

Dr Mahesh Kumar at World Vaccine Congress Washington 2017

Mr Keith L Knutson, Professor of Immunology, Mayo Clinic

Mr Keith L Knutson at World Vaccine Congress Washington 2017

Ms Nathalie Landry, Executive Vice President of Product Development, Medicago Inc

Professor Bruce Levine, Professor, Perelman School of Medicine, University of Pennsylvania

Dr Myron M. Levine, Grollman Distinguished Professor and Director, Center for Vaccine Development, University of Maryland School of Medicine

Mr Thomas Lingelbach, President and Chief Executive Officer, Valneva SE

Daniel Littlefield, Principal, Modality Solutions LLC

Dr Leslie Lobel, Senior Medical Advisor – Medical Expert Office, ClinicalRM

Dr Charles Lutsch, AVP R&D, Sanofi

Dr Richard Malley, Scientific Founder, Affinivax

Valerie Marshall, Commander, Policy Analyst, Office of Vaccines Research and CBER, Food and Drug Administration

Dr Tyler Martin, CEO, Adjuvance Technologies

Dr Laura Martin, Head of Project Portfolio, G.S.K. Vaccines Institute for Global Health

Ms Karen McCarthy, Senior Director, Project Management, PPD Vaccines

Ms Karen McCarthy at World Vaccine Congress Washington 2017

Dr Douglas Mcneel, Chief Scientific Founder and Head of M.V.I. Scientific Advisory Board, Madison Vaccines Inc.

Mr Timothy Miller, CSO, Agri Laboratories Ltd

Professor James Moon, Assistant Professor of Biomedical Informatics, University of Michigan

Mr Jeffrey Moore, President, MP Healthcare Venture

Dr Vasee Moorthy, Team Leader, Vaccine Development Initiative for Vaccine Research, Department of Immunization, Vaccines & Biologicals, World Health Organisation

Dr Sally Mossman, VP, Head Discovery Performance Unit, US, GSK Vaccines

Mr Wilhelm (Willie) Muehlhausen, VP eCOA & Innovation, ICON Clinical Research

Mr Wilhelm (Willie) Muehlhausen at World Vaccine Congress Washington 2017

Dr Egbert Mundt, Head of Global Poultry Vaccine R&D, Boehringer Ingelheim

Mr Vincent Munster, Chief of Virus Ecology Unit, N.I.A.I.D. N.I.H.

Mr Vincent Munster at World Vaccine Congress Washington 2017

Dr Gary Nabel, Chief Scientific Officer & Senior Vice President Head, North America R&D Hub, Sanofi

Mr Stephen Nagler, Executive Director, MedPro Investors LLC

Mr Stephen Nagler at World Vaccine Congress Washington 2017

Dr Ruslan Novosiadly, Senior Research Advisor Cancer Immunobiology Biomarkers, Eli Lilly and Co

Dr Ruslan Novosiadly at World Vaccine Congress Washington 2017

Dr Derek O'Hagan, Global Head of Vaccine Chemistry and Formulation Research, GSK Vaccines

Dr Ole Olesen, Director, E.D.C.T.P.

Professor Ab Osterhaus, Director, Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover

Dr Peter Palese, PROFESSOR and CHAIR Microbiology, Mount Sinai School of Medicine

Dr Misha Petkevich, Chief Investment Officer, V2M Capital LLC

Dr Misha Petkevich at World Vaccine Congress Washington 2017

Professor Stanley Plotkin, Emeritus Professor, University of Pennsylvania School of Medicine

Dr Gregory A. Poland, Director of Mayo Vaccine Research Group, Mayo Clinic and Foundation

Dr Steve Projan, Senior Vice President of Innovative Medicines, Research and Development and Head of Infectious Diseases and Vaccines, MedImmune Inc

Professor Bali Pulendran, Professor in the Department of Pathology and Laboratory Medicine, Emory School of Medicine & Emory Vaccine Center

Dr Rino Rappuoli, Chief Scientist, GSK Vaccines

Dr GS Reddy, Chief General Manager, Manufacturing, Indian Immunologicals Ltd

Dr Steven Reed, President and Founder, Infectious Disease Research Institute

Mr Scott Requadt, Principal, Clarus Ventures

Matt Roberge, Senior Director, Local Market Access & Support, Pfizer

Mr Scot Roberts, Chief Scientific Officer, Altimmune

Mr Scot Roberts at World Vaccine Congress Washington 2017

Dr Ted Ross, Director, Vaccines & Infectious Diseases, University of Georgia

Dr Jerald Sadoff, Senior Advisor, Janssen Infectious Diseases and Vaccines

Professor Ugur Sahin, Co Founder and Chief Executive Office, BioNTech Ag

Mr Sonny Saksena, Managing Director, Finles Capital Management

Mr Sonny Saksena at World Vaccine Congress Washington 2017

Dr Gautam Sanyal, Fellow, Analytical Sciences, Biopharmaceutical Development, MedImmune Inc

Dr Niranjan Sardesai, COO, Inovio

Dr Darin Seehafer, Clinical Scientist/Program Director, PRA Health Sciences

Alessandro Sette, Center Head, Division Head, and Professor Center for Infectious Disease, La Jolla Infectious Disease Institute

Alessandro Sette at World Vaccine Congress Washington 2017

Dr George Siber, CSO of ClearPath Vaccines & Scientific Advisory Board of Genocea, ClearPath Vaccines

Mr Manmohan Singh, Senior Director, Drug Product Development, Takeda Pharmaceuticals

Mr Manmohan Singh at World Vaccine Congress Washington 2017

Dr William Smith, President & Medical Director, NOCCR

Mr Bruno Speder, Head of Clinical Regulatory Affairs, S.G.S. Life Science Services

Mr Lars Staal Wegner, Vice President of Commercial Affairs, Bavarian Nordic A/S

Dr Steven Swanson, Senior Vice President, Research, Immunocellular Therapeutics

Dr Jim Tartaglia, Vice President New Vaccine Project Head North America, Sanofi Pasteur

Dr Frank Tomaka, Senior Director, Clinical Lead HIV/STI Vaccines, Janssen Infectious Diseases and Vaccines

Dr Frank Tomaka at World Vaccine Congress Washington 2017

Dr Sean Tucker, CSO and VP Research, Vaxart

Dr Jeffrey Ulmer, Head, Preclinical R&D US, GSK Vaccines

Dr Kumaran Vadivelu, Medical Director, Global Medical Lead, Meningococcal Vaccines, GSK Vaccines

Dr Kumaran Vadivelu at World Vaccine Congress Washington 2017

Dr Michael Vajdy, Co Founder, President and Chief Scientific Officer, Epito Genesis Inc

Dr Michael Vajdy at World Vaccine Congress Washington 2017

Dr Bernard Vallat, Honorary Director General, Office International Des Epizooties

Dr Bernard Vallat at World Vaccine Congress Washington 2017

Dr Willie Vann, Chief, Laboratory of Bacterial Polysaccharides, CBER, F.D.A.

Dr Willie Vann at World Vaccine Congress Washington 2017

Dr Daniel Vellom, Senior Director Global Technology Innovation, Sanofi Pasteur

Mr Richard Walker, Director of Enteric Vaccine Initiative, PATH

I-Ming Wang, Associate Scientific Director, Principal Scientist, Molecular Profiling Site Lead, Merck & Co.

Dr Julie Waterbury, Executive Director, Global Vaccine Strategy & Innovation, Merck & Co.

Professor David Weiner, Professor & WW Smith Chair in Cancer Research Director Wistar Vaccine Center & Executive Vice President, The Wistar Institute

Dr Joanne Wildenbeest, Associate Professor Paediatric Infectious Diseases and Immunology, University Medical Center Utrecht

Adrian Wildfire, Project Director - Infectious Diseases & Viral Infection Unit, SGS Life Science Services

Dr Mahesh Yadav, Research and Early Development Scientist, Genentech

Dr Mahesh Yadav at World Vaccine Congress Washington 2017

Dr Christopher Yallop, Chief Operations and Scientific Officer, Batavia Biosciences

Dr Masahide Yano, Research Scientist, US Food and Drug Administration

Dr Masahide Yano at World Vaccine Congress Washington 2017

Mr Peter Young, Executive In Residence, Pappas Capital

Mr Lei Zheng, Assistant Professor of Oncology, Johns Hopkins School of Medicine

Mr Glen Zimmermann, Senior Director Business Development, West Pharmaceutical Services

Mr Glen Zimmermann at World Vaccine Congress Washington 2017





Get involved

To exhibit, sponsor or speak at the event contact
Marc Rhys-Evans on +44 (0)20 7827 5945
or marc.rhys-evans@terrapinn.com